| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 |
Biocryst Pharmaceuticals Inc.
BCRX
|
BUY |
$17.00
Est. +78%
|
$9.55 | $11.22 |
Pending
|
$9.58
+0.3%
|
| May 14, 2026 |
Tango Therapeutics Inc
TNGX
|
BUY |
$27.00
Est. +6%
|
$25.51 | $33.53 |
Target Met
|
$26.72
+4.7%
|
| May 12, 2026 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$33.00
Est. +189%
|
$11.43 | $12.88 |
Pending
|
$9.08
-20.6%
|
| Apr 30, 2026 |
Bicycle Therapeutics Plc - ADR
BCYC
|
BUY |
$12.00
Est. +154%
|
$4.72 | $5.22 |
Pending
|
$3.95
-16.3%
|
| Mar 13, 2026 |
Precision Biosciences Inc
DTIL
|
BUY |
$19.00
Est. +235%
|
$5.67 | $9.62 |
Pending
|
$7.25
+27.9%
|
| Mar 09, 2026 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$98.00
Est. +24%
|
$79.23 | $107.03 |
Target Met
|
$104.49
+31.9%
|
| Mar 05, 2026 |
Tango Therapeutics Inc
TNGX
|
BUY |
$18.00
Est. +7%
|
$16.83 | $33.53 |
Target Met
|
$26.72
+58.8%
|
| Mar 05, 2026 |
Compass Therapeutics Inc
CMPX
|
BUY |
$9.00
Est. +63%
|
$5.53 | $6.85 |
Pending
|
$2.08
-62.4%
|
| Dec 30, 2025 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$0.50
Est. +72%
|
$0.29 | $0.78 |
Target Met
|
$0.30
+4.2%
|
| Oct 17, 2025 |
Kezar Life Sciences Inc
KZR
|
BUY |
$7.00
Est. +68%
|
$4.17 | $7.55 |
Target Met
|
$7.29
+74.8%
|
| Oct 14, 2025 |
Biocryst Pharmaceuticals Inc.
BCRX
|
BUY |
$15.00
Est. +134%
|
$6.42 | $11.22 |
Pending
|
$9.58
+49.2%
|
| Sep 10, 2025 |
Travere Therapeutics Inc
TVTX
|
BUY |
$35.00
Est. +28%
|
$27.31 | $60.10 |
Target Met
|
$56.68
+107.5%
|
| Sep 08, 2025 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$51.00
Est. +60%
|
$31.80 | $107.03 |
Target Met
|
$104.49
+228.6%
|
| Aug 25, 2025 |
Valneva SE - ADR
VALN
|
BUY |
$14.00
Est. +48%
|
$9.43 | $12.22 |
Pending
|
$4.96
-47.4%
|
| Dec 31, 2024 |
Sangamo Therapeutics Inc
SGMO
|
BUY |
$3.00
Est. +194%
|
$1.02 | $1.45 |
Miss
|
$0.07
-92.7%
|
| Nov 18, 2024 |
Erasca Inc
ERAS
|
BUY |
$6.00
Est. +150%
|
$2.40 | $3.29 |
Miss
|
$18.87
+686.3%
|
| Nov 15, 2024 |
Cue Biopharma Inc
CUE
|
BUY |
$4.00
Est. +210%
|
$1.29 | $52.50 |
Target Met
|
$32.57
+2424.8%
|
| Aug 05, 2024 |
Biocryst Pharmaceuticals Inc.
BCRX
|
BUY |
$11.00
Est. +46%
|
$7.51 | $11.31 |
Precision Hit (±3%)
|
$9.58
+27.6%
|
| May 28, 2024 |
Calliditas Therapeutics AB - ADR
CALT
|
BUY |
$39.00
Est. +3%
|
$37.96 | $43.00 |
Target Met
|
$40.00
+5.4%
|
| May 23, 2024 |
Calliditas Therapeutics AB - ADR
CALT
|
BUY |
$58.00
Est. +155%
|
$22.75 | $43.00 |
Miss
|
$40.00
+75.8%
|
| May 07, 2024 |
Prime Medicine Inc
PRME
|
BUY |
$15.00
Est. +178%
|
$5.40 | $6.75 |
Miss
|
$3.01
-44.3%
|
| May 02, 2024 |
Aurinia Pharmaceuticals Inc
AUPH
|
BUY |
$6.00
Est. +18%
|
$5.10 | $10.67 |
Target Met
|
$15.22
+198.4%
|
| Mar 13, 2024 |
Cue Biopharma Inc
CUE
|
BUY |
$6.00
Est. +179%
|
$2.15 | $67.80 |
Target Met
|
$32.57
+1414.9%
|
| Mar 06, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$46.00
Est. +37%
|
$33.58 | $61.90 |
Target Met
|
$9.08
-73.0%
|
| Jan 23, 2022 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$205.00
Est. +50%
|
$136.53 | - | - |
$278.40
+103.9%
|
| Sep 20, 2021 |
Mirati Therapeutics Inc
MRTX
|
BUY |
$193.00
Est. +9%
|
$177.45 | - | - |
$58.70
-66.9%
|
| Aug 09, 2021 |
Biocryst Pharmaceuticals Inc.
BCRX
|
BUY |
$19.00
Est. +8%
|
$17.65 | - | - |
$9.58
-45.7%
|
| Jun 22, 2021 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$109.00
Est. +38%
|
$78.91 | - | - |
$10.67
-86.5%
|
| Apr 21, 2021 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$172.00
Est. +38%
|
$124.93 | - | - |
$46.73
-62.6%
|